Overcoming phenotypic switching: targeting protein-protein interactions in cancer
Alternative protein-protein interactions (PPIs) arising from mutations or post-translational modifications (PTMs), termed phenotypic switching (PS), are critical for the transmission of alternative pathogenic signals and are particularly significant in cancer. In recent years, PPIs have emerged as p...
Main Authors: | Christos Ladias, Pavlos Papakotoulas, Maria Papaioannou, Nikolaos A. Papanikolaou |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2023-10-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/1002181 |
Similar Items
-
Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
by: Sarah Allegra, et al.
Published: (2023-09-01) -
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia
by: Kota Yoshifuji, et al.
Published: (2022-10-01) -
Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia
by: Francesca Musumeci, et al.
Published: (2018-11-01) -
Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
by: Mario Tiribelli, et al.
Published: (2019-08-01) -
Low-Intensity and Chemo-Free Treatments in Ph+ ALL: Progression-Free Survival Based on Indirect Comparisons
by: Melania Rivano, et al.
Published: (2023-11-01)